Moshe Ephrat, MD, FACS
Dr. Moshe Ephrat is currently participating in two clinical research studies for people with Chronic Rhinosinusitis - For more information, or if you or someone you know may qualify, please visit the below links:
COVID-19 Series I: www.XENTlivestream.com
COVID-19 Series II: www.XENTwebinar.com
Dr. Moshe Ephrat is a fellowship trained and Board Certified ENT surgeon having over 20 years of expertise with specialized interests in nasal/sinus surgery, rhinoplasty and facial rejuvenation. Dr. Ephrat was awarded and completed a fellowship devoted to facial plastic and reconstructive surgery.
Dr. Ephrat has academic appointments as an Assistant Clinical Professor for the Mount Sinai School of Medicine as well as the Zucker School of Medicine at Hofstra/Northwell. He also has held a leadership position as the President of the Long Island Society of Otolaryngology – Head and Neck Surgery. His media appearances include The Dr. Oz Show, CBS news and News 12 Long Island. Dr. Ephrat maintains membership in many national, state and local societies including the AAFPRS, AAOHNS, LISO, ARS, and MSSNY.
Dr. Ephrat is consistently among the first in the area to offer new breakthrough medical technologies. Patients with chronic sinusitis, nasal obstruction and nasal polyps can now be treated In-Office with state of the art equipment, including the Medtronic Image Guidance System, allowing unparalleled patient safety. This allows patients relief without general anesthesia and quicker recovery. The VivAer procedure is offered to patients with nasal obstruction and nasal valve collapse.
Educational videos and images may be watched on his social media sites including YouTube: DrEphratVideo, Instagram @DrEphrat and @PolypDoc. These sites allow exploration of the variety of treatments Dr. Ephrat manages both in the office and the operating room theater.
Some of the cutting edge technologies that Dr. Ephrat uses to manage nasal polyps and chronic sinusitis include 3D image guidance sinus surgery, PolypVac / suction powered debriders, PROPEL family of self-dissolving implants, SINUVA implant and topical steroid treatments to avoid the unwanted effects of systemic steroids.
Dr. Ephrat is also in the forefront of clinical research and recently published results of a research trial used in the FDA approval of a novel new treatment for nasal valve collapse and nasal obstruction - The VivAer procedure is minimally invasive and requires 15 minutes in the office (https://onlinelibrary.wiley.com/doi/full/10.1002/lio2.247) He will also be a principal investigator in a research trial for a medical treatment used for nasal polyps.
If you regularly experience difficulty breathing through your nose and nothing seems to help, you may have nasal airway obstruction. Until now, finding a long-term solution often meant surgery. Dr. Ephrat offers the VivAer treatment, a non-invasive treatment to open your nasal airway.
Common symptoms of nasal airway obstruction
- Trouble breathing through your nose
- Nasal congestion
- Difficulty sleeping
- Difficulty breathing during physical exertion
- Non-invasive, no incisions
- Typically done in the doctor's office under local anesthesia
- Minimal to no downtime after treatment
- Long-lasting results
The VivAer treatment is clinically shown to provide high satisfaction and lasting relief.¹
Patients typically return to normal daily activity the same day.*
- 97% of patients experienced significant improvement in nasal breathing¹
- 94% of patients improved their ability to get enough air through their nose during exercise or exertion2
- 89% of patients reported getting a better night’s sleep2
Call Dr. Ephrat to find out if you are a candidate for VivAer. To learn more visit VivAer.com.
*Individual results may vary.
¹ Ephrat M, Jacobowitz O, Driver M. Quality-of-life impact after in-office treatment of nasal valve obstruction with a radiofrequency device: 2-years results from a multicenter prospective clinical trial. Int Forum Allergy Rhinol. 2021;11:755-765.
2 Prospective, Multi-Center, Non-Randomized Study to Evaluate the Quality of Life Impact After Treatment of Nasal Airway Obstruction Using the Aerin Medical VivAer Stylus. Aerin Medical Report TR680-01.
Published On: 11/08/2021
Moshe Ephrat, MD, FACS accepts the following insurance plans:
Lake Success Office:
- Affinity Health Plan
- BC/BS Empire NY
- BC/BS HealthPlus
- BCBS HealthPlus Gatekeeper
- EmblemHealth GHI
- Empire Plan (UHC)
- HealthCare Partners IPA
- WTC Health For Heroes
- Humana Medicare
- Local 1199
- Magnacare Northwell Direct
- Oxford Freedom
- Partners Direct Health
- Partners Health Plan
- Railroad Medicare
- UHC Oxf Liberty
- US Family Health
- Wellcare HMO/Medicare
News & Press
Published On: 12/16/2011
Published On: 12/05/2011